115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial and ethnic differences in breast inflammation and its association with lymphedema risk after axillary lymph node dissection
    Journal Article

    Roberts, A.; Campbell, A. C.; Pollack, B. L.; Montagna, G.; Sevilimedu, V.; Axelrod, B.; Gomez, E. A.; Giri, D.; Morrow, M.; Mehrara, B. J.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Robotic versus open placement of hepatic artery infusion pumps
    Journal Article

    Schleimer, L. E.; Liu, A.; Kalvin, H. L.; Barekzai, A. B.; Choubey, A. P.; Jung, J.; Haque, R.; Jarnagin, W. R.; Balachandran, V. P.; Geevarghese, R.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: A pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials
    Journal Article

    Williams, H.; Fokas, E.; Diefenhardt, M.; Lee, C.; Verheij, F. S.; Omer, D. M.; Lin, S. T.; Dunne, R. F.; Marcet, J.; Cataldo, P.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Protective factors associated with normal lymphatic function after axillary lymph node dissection for breast cancer treatment
    Journal Article

    Coleman-Belin, J. C.; Rubin, J.; Boe, L. A.; Diwan, R.; Monge, J. J. L.; Dinh, D. D.; Bloomfield, E.; Mehrara, B.; Coriddi, M.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: Final analysis of the phase III JAVELIN Renal 101 trial
    Journal Article

    Choueiri, T. K.; Penkov, K.; Uemura, H.; Campbell, M. T.; Pal, S.; Kollmannsberger, C.; Lee, J. L.; Venugopal, B.; van den Eertwegh, A. J. M.; Negrier, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Biomarker analyses from the phase III randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Grünwald, V.; George, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Breast carcinomas resembling acinic cell carcinoma: Comprehensive analysis of 14 cases and review of the literature
    Review

    Qin, F.; Li, J.; Zheng, Y.; Jiang, C.; Jia, Y.; Sun, H.; Xue, H.; Wang, X.; Wang, L.; Qian, X.; more...
    American Journal of Surgical Pathology (2025)

    Fulltext@MSK | Save
  • Venetoclax–azacitidine versus azacitidine for the treatment of primary refractory or first relapsed acute myeloid leukemia. An IPC-DATAML-MSKCC retrospective study
    Correspondence

    Petit, C.; Higue, J.; Acheaibi, Z.; Gilhodes, J.; Hospital, M. A.; Devillier, R.; Bewersdorf, J.; Goldberg, A. D.; Pigneux, A.; Vey, N.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Executive summary of the American Radium Society Appropriate Use Criteria: Regional nodal irradiation for breast cancer
    Guidelines

    Expert Panel on Breast Cancer; Freedman, G. M.; Guttmann, D. M.; Ahmed, K.; Gao, W.; Walker, E. M.; Harris, E. E.; Gonzalez, V.; Ye, J.; Nead, K.; more...
    American Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Diet and survival after a diagnosis of ovarian cancer: A pooled analysis from the Ovarian Cancer Association Consortium
    Journal Article

    Nagle, C. M.; Ibiebele, T. I.; Na, R.; Bandera, E. V.; Cramer, D.; Doherty, J. A.; Giles, G. G.; Goodman, M. T.; Hanley, G. E.; Harris, H. R.; more...
    American Journal of Clinical Nutrition (2025)

    Fulltext@MSK | Save